NeoGenomics, Inc. (NEO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.92 |
| Open | 14.00 |
| Bid | 13.94 x 200 |
| Ask | 14.00 x 100 |
| Day's range | 13.51 - 14.36 |
| 52-week range | 11.03 - 21.22 |
| Volume | |
| Avg. volume | 945,824 |
| Market cap | 1.783B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.73 |
Simply Wall St.NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
- GuruFocus.com
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.
ZacksHere's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings
While the top- and bottom-line numbers for NeoGenomics (NEO) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
© 2024 Yahoo. All rights reserved.